États-Unis · Plateformes & données · MarketBeat

Opus Genetics (NASDAQ:IRD) Price Target Raised to $14.00

Publié par MarketBeat · États-Unis il y a 36 min

Image from MarketBeat Media, LLC. · MarketBeat

Résumé détaillé

HC Wainwright boosted their price objective on shares of Opus Genetics from $8.00 to $14.00 and gave the company a "buy" rating in a report on Wednesday.

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

Opus Genetics (NASDAQ:IRD) Price Target Raised to $14.00

Résumé détaillé

À lire aussi

22 stocks of companies with tremendous sales growth

Coinbase Global vs. Toast: Which Financial Stock Is a Better Buy for 2027?

Automatic Data Processing raises dividend by 11.8% to $1.90

Best Stocks Under $5

Conduit Re Q3 2026 slides: margin focus drives portfolio shift

Alibaba announces plans to list T-Head, its Nvidia chip rival

Opus Genetics (NASDAQ:IRD) Price Target Raised to $14.00

Résumé détaillé

Partager

À lire aussi

22 stocks of companies with tremendous sales growth

Coinbase Global vs. Toast: Which Financial Stock Is a Better Buy for 2027?

Automatic Data Processing raises dividend by 11.8% to $1.90

Best Stocks Under $5

Conduit Re Q3 2026 slides: margin focus drives portfolio shift

Alibaba announces plans to list T-Head, its Nvidia chip rival